In Segment C, individuals will acquire ABBV-744 and oral navitoclax. In Phase D, members will acquire ABBV-744 and ruxolitinib. Participants will acquire treatment until eventually illness progression or perhaps the members are not able to tolerate the study drugs. and afterwards endorse H3K27Ac at this location. Chromatin hyperacetylation could increase https://timf444seo7.blog-mall.com/profile